← Open Payments lookup

ELIANA VILLADO: Open Payments

NPI 1316505175 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$327 in 16 payments from 9 companies in 2025. Trend: 2023 $601 · 2024 $79 · 2025 $327

Food & beverage: $327
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$75
Veloxis Pharmaceuticals, Inc.2$71
KYOWA KIRIN, INC.2$47
Apellis Pharmaceuticals, Inc.2$35
CorMedix Inc.1$24
Otsuka America Pharmaceutical, Inc.1$21
Travere Therapeutics, Inc.1$20
Alexion Pharmaceuticals, Inc.1$17
Boehringer Ingelheim Pharmaceuticals, Inc.1$16

Products named: FARXIGA, ENVARSUS, CRYSVITA, Empaveli, DEFENCATH, JYNARQUE, ULTOMIRIS, JARDIANCE.

Industry payments across TX — which companies pay providers there.